Nikolaos Panagiotopoulos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Nikolaos Panagiotopoulos has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Georgios Geropoulos
Third Department of Surgery, University General Hospital of Thessaloniki AHEPA, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece
6 shared publications David Lawrence
Department of Thoracic Surgery, University College London Hospitals NHS Foundation Trust, London, UK
5 shared publications- Davide Patrini
Department of Cardiothoracic Surgery, University College London Hospitals (UCLH), London, UK
4 shared publications - Sofoklis Mitsos
Department of Thoracic Surgery, Attikon General Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece
4 shared publications - David Lawrence
Department of Cardiothoracic Surgery, The Heart Hospital, University College London
3 shared publications Davide Patrini
Department of Thoracic Surgery, University College London Hospitals NHS Foundation Trust, London, UK
3 shared publications
Latest Publications
- Open Access
- 17 January 2023
- Published by Springer Nature in Cureus
- Vol. 15 (1) , e33885
Robotic Sympathectomy for Hyperhidrosis
In hyperhidrosis, the body’s sweat glands overact. Excessive sweating results from this overactivity, and for many hyperhidrosis patients, managing symptoms can be difficult in day-to-day life. Both surgical and non-surgical types of treatment are available for hyperhidrosis. Surgical treatments include microwave sympathectomy (video-assisted thoracic surgery and robotic). Da Vinci Si and Xi robotic systems are used. This review summarizes the outcomes, complications, advantages, and disadvantages of robotic sympathectomy. We conducted a literature search using PubMed, Cochrane, and Scopus. After analyzing nine articles, we found that robotic sympathectomy decreased compensatory hyperhidrosis with similar outcomes to other procedures. Robotic sympathectomy also reduced complications of Horner syndrome and has changed minimally invasive surgery significantly due to the reduction in tremors by a surgeon’s hands to three-dimensional magnified views. It can potentially address the limitations of human video-assisted sympathectomy. However, the higher cost of robotic surgery, longer perioperative time due to the setting up of the machine, and higher training requirements are some of the disadvantages. The advantages of robotic sympathectomy are a reduction in compensatory sweating, better dexterity, loss of tremors, better visualization, and better accuracy. Although the overall success rates seem to be similar between robotic and video-assisted approaches, more studies are needed.
- 17 January 2023
- Published by Springer Nature in Cureus
- Vol. 15 (1) , e33885
Open AccessRobotic Sympathectomy for Hyperhidrosis
In hyperhidrosis, the body’s sweat glands overact. Excessive sweating results from this overactivity, and for many hyperhidrosis patients, managing symptoms can be difficult in day-to-day life. Both surgical and non-surgical types of treatment are available for hyperhidrosis. Surgical treatments include microwave sympathectomy (video-assisted thoracic surgery and robotic). Da Vinci Si and Xi robotic systems are used. This review summarizes the outcomes, complications, advantages, and disadvantages of robotic sympathectomy. We conducted a literature search using PubMed, Cochrane, and Scopus. After analyzing nine articles, we found that robotic sympathectomy decreased compensatory hyperhidrosis with similar outcomes to other procedures. Robotic sympathectomy also reduced complications of Horner syndrome and has changed minimally invasive surgery significantly due to the reduction in tremors by a surgeon’s hands to three-dimensional magnified views. It can potentially address the limitations of human video-assisted sympathectomy. However, the higher cost of robotic surgery, longer perioperative time due to the setting up of the machine, and higher training requirements are some of the disadvantages. The advantages of robotic sympathectomy are a reduction in compensatory sweating, better dexterity, loss of tremors, better visualization, and better accuracy. Although the overall success rates seem to be similar between robotic and video-assisted approaches, more studies are needed.
- Open Access
- 27 July 2022
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 93 (2)
Pneumomediastinum in the COVID-19 era: to drain or not to drain?
Pneumomediastinum (PNM) is a rare clinical finding, usually with a benign course, which is managed conservatively in the majority of cases. However, during the COVID-19 pandemic, an increased incidence of PNM has been observed. Several reports of PNM cases in COVID-19 have been reported in the literature and were managed either conservatively or surgically. In this study, we present our institutional experience of COVID-19 associated PNM, propose a management algorithm, and review the current literature. In total, 43 Case Series were identified, including a total of 747 patients, of whom 374/747 (50.1%) were intubated at the time of diagnosis, 168/747 (22.5%) underwent surgical drain insertion at admission, 562/747 (75.2%) received conservative treatment (observation or mechanical ventilation. Inpatient mortality was 51.8% (387/747), while 45.1% of the population recovered and/or was discharged (337/747). In conclusion, with increased incidence of PNM in COVID-19 patients reported in the literature, it is still difficult to assign a true causal relationship between PNM and mortality. We can, however, see that PMN plays an important role in disease prognosis. Due to increased complexity, high mortality, and associated complications, conservative management may not be sufficient, and a surgical approach is needed.
- 27 July 2022
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 93 (2)
Open AccessPneumomediastinum in the COVID-19 era: to drain or not to drain?
Pneumomediastinum (PNM) is a rare clinical finding, usually with a benign course, which is managed conservatively in the majority of cases. However, during the COVID-19 pandemic, an increased incidence of PNM has been observed. Several reports of PNM cases in COVID-19 have been reported in the literature and were managed either conservatively or surgically. In this study, we present our institutional experience of COVID-19 associated PNM, propose a management algorithm, and review the current literature. In total, 43 Case Series were identified, including a total of 747 patients, of whom 374/747 (50.1%) were intubated at the time of diagnosis, 168/747 (22.5%) underwent surgical drain insertion at admission, 562/747 (75.2%) received conservative treatment (observation or mechanical ventilation. Inpatient mortality was 51.8% (387/747), while 45.1% of the population recovered and/or was discharged (337/747). In conclusion, with increased incidence of PNM in COVID-19 patients reported in the literature, it is still difficult to assign a true causal relationship between PNM and mortality. We can, however, see that PMN plays an important role in disease prognosis. Due to increased complexity, high mortality, and associated complications, conservative management may not be sufficient, and a surgical approach is needed.
- Open Access
- 27 September 2021
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2021 (9) , rjab412
Small lymphocytic lymphoma and lung malignancy coincidence in a male patient: a case report and literature review
Lung carcinoma management secondary to chronic lymphocytic leukemia could be quite challenging. We report a case of a 60-year-old male with several co-morbidities, who presented with shortness of breath and persistent cough. A chest imaging showed a right pleural effusion and complete white-out of the right chest cavity. A computed tomography scan revealed consolidation of the right upper lobe with a 6-cm lesion in hilum with complete occlusion of right lobe bronchus. The patient underwent a video-assisted thoracoscopic surgery, drainage of pleural effusion and pleural and lung biopsy. Talc pleurodesis as well as a flexible bronchoscopy of the endobronchial lesion was performed. Histopathological examination showed a small B-cell lymphoma of the right pleura and an invasive non-small cell carcinoma of the right lung. Dual neoplasms are challenging in terms of diagnosing, and they usually require a multidisciplinary team for the right treatment strategy, including surgery and chemotherapy.
- 27 September 2021
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2021 (9) , rjab412
Open AccessSmall lymphocytic lymphoma and lung malignancy coincidence in a male patient: a case report and literature review
Lung carcinoma management secondary to chronic lymphocytic leukemia could be quite challenging. We report a case of a 60-year-old male with several co-morbidities, who presented with shortness of breath and persistent cough. A chest imaging showed a right pleural effusion and complete white-out of the right chest cavity. A computed tomography scan revealed consolidation of the right upper lobe with a 6-cm lesion in hilum with complete occlusion of right lobe bronchus. The patient underwent a video-assisted thoracoscopic surgery, drainage of pleural effusion and pleural and lung biopsy. Talc pleurodesis as well as a flexible bronchoscopy of the endobronchial lesion was performed. Histopathological examination showed a small B-cell lymphoma of the right pleura and an invasive non-small cell carcinoma of the right lung. Dual neoplasms are challenging in terms of diagnosing, and they usually require a multidisciplinary team for the right treatment strategy, including surgery and chemotherapy.
- Open Access
- 8 March 2021
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 91 (3)
The challenging management of a giant intrathoracic desmoid tumour: a case report
Desmoid tumours are rare, locally aggressive neoplasms exhibiting high tendency for recurrence, even after complete resection. Only 1 in 5 of them originates from the chest wall, usually measuring less than 10 cm at diagnosis. Herein, we report the case of a woman presenting with symptoms of gradual lung compression by a giant desmoid tumour occupying the entire hemithorax. She underwent complete surgical resection of the tumour and chest wall reconstruction. She had disease recurrence 15 months later and currently remains under regular follow-up. The management of intrathoracic desmoid tumours is challenging because they are usually not diagnosed until they become large enough to cause compression symptoms. While medical management is the primary modality of treatment, surgery could be considered in selected cases where significant symptoms arise, and the functional status is impaired secondary to the tumour. Adjuvant radiotherapy to minimise the risk of local recurrence should also be considered.
- 8 March 2021
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 91 (3)
Open AccessThe challenging management of a giant intrathoracic desmoid tumour: a case report
Desmoid tumours are rare, locally aggressive neoplasms exhibiting high tendency for recurrence, even after complete resection. Only 1 in 5 of them originates from the chest wall, usually measuring less than 10 cm at diagnosis. Herein, we report the case of a woman presenting with symptoms of gradual lung compression by a giant desmoid tumour occupying the entire hemithorax. She underwent complete surgical resection of the tumour and chest wall reconstruction. She had disease recurrence 15 months later and currently remains under regular follow-up. The management of intrathoracic desmoid tumours is challenging because they are usually not diagnosed until they become large enough to cause compression symptoms. While medical management is the primary modality of treatment, surgery could be considered in selected cases where significant symptoms arise, and the functional status is impaired secondary to the tumour. Adjuvant radiotherapy to minimise the risk of local recurrence should also be considered.
- Open Access
- 5 March 2021
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 91 (2)
Metastatic mandibular ameloblastoma of the lung ten years after primary resection: A rare case report
Ameloblastoma is a rare odontogenic neoplasm of the jaw. It usually behaves as a benign, slow growing tumour of the oral cavity with a high recurrence rate, especially when it is inadequately resected. A small proportion of ameloblastomas metastasize to distant organs, with lungs representing the most common site of metastatic spread. In this report, we present the case of a middle-aged man with two pulmonary nodules and a history of mandibular ameloblastoma excised 10 years prior to this radiological finding. Following resection and histopathological analysis of the lung lesion, a diagnosis of metastatic ameloblastoma was confirmed. No local recurrence of the primary tumour was identified. At 1-year follow-up, the patient had no evidence of local or metastatic disease.
- 5 March 2021
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 91 (2)
Open AccessMetastatic mandibular ameloblastoma of the lung ten years after primary resection: A rare case report
Ameloblastoma is a rare odontogenic neoplasm of the jaw. It usually behaves as a benign, slow growing tumour of the oral cavity with a high recurrence rate, especially when it is inadequately resected. A small proportion of ameloblastomas metastasize to distant organs, with lungs representing the most common site of metastatic spread. In this report, we present the case of a middle-aged man with two pulmonary nodules and a history of mandibular ameloblastoma excised 10 years prior to this radiological finding. Following resection and histopathological analysis of the lung lesion, a diagnosis of metastatic ameloblastoma was confirmed. No local recurrence of the primary tumour was identified. At 1-year follow-up, the patient had no evidence of local or metastatic disease.
- Open Access
- 10 July 2020
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 90 (3) , 533-536
Cystic fibrohistiocytic tumour of the lung presenting with recurrent pneumothoraces: a case report
Cystic fibrohistiocytic tumour of the lung is a very rare pathological entity that occurs either as a primary pulmonary neoplasm or as a metastasis from skin lesions called cellular fibrous histiocytomas. Herein, we present the case of a 19-year old man with a history of recurrent pneumothoraces who was managed surgically and was eventually diagnosed with cystic fibrohistiocytic tumour of the lung. Clinicians should include this disease in the differential diagnosis of pulmonary cystic lesions and be aware of its association with cellular fibrous histiocytoma. Reporting of more cases is warranted to further elucidate the natural course of the disease and optimise its management.
- 10 July 2020
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 90 (3) , 533-536
Open AccessCystic fibrohistiocytic tumour of the lung presenting with recurrent pneumothoraces: a case report
Cystic fibrohistiocytic tumour of the lung is a very rare pathological entity that occurs either as a primary pulmonary neoplasm or as a metastasis from skin lesions called cellular fibrous histiocytomas. Herein, we present the case of a 19-year old man with a history of recurrent pneumothoraces who was managed surgically and was eventually diagnosed with cystic fibrohistiocytic tumour of the lung. Clinicians should include this disease in the differential diagnosis of pulmonary cystic lesions and be aware of its association with cellular fibrous histiocytoma. Reporting of more cases is warranted to further elucidate the natural course of the disease and optimise its management.
- 1 July 2020
- Published by Elsevier in Respiratory Medicine
- Vol. 168, 105995
Focus on the pulmonary involvement and genetic patterns in Birt-Hogg-Dubè syndrome: Literature review
- 1 July 2020
- Published by Elsevier in Respiratory Medicine
- Vol. 168, 105995
Focus on the pulmonary involvement and genetic patterns in Birt-Hogg-Dubè syndrome: Literature review
- Open Access
- 1 June 2018
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 10 (S16) , S1930-S1933
Pulmonary metastasectomy and laser-assisted resection
Pulmonary metastasectomy and laser-assisted resection
- 1 June 2018
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 10 (S16) , S1930-S1933
Open AccessPulmonary metastasectomy and laser-assisted resection
Pulmonary metastasectomy and laser-assisted resection
- Open Access
- 3 June 2017
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 22, 19-23
Mediastinal hemangioendothelioma: Case report and review of the literature
- 3 June 2017
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 22, 19-23
Open AccessMediastinal hemangioendothelioma: Case report and review of the literature
- 1 November 2016
- Published by AME Publishing Company in ASVIDE
- Vol. 3 (1) , 461
Dissection station 2 and 4 on the right hemithorax
- 1 November 2016
- Published by AME Publishing Company in ASVIDE
- Vol. 3 (1) , 461
Dissection station 2 and 4 on the right hemithorax